TransMedics (TMDX) Receivables (2018 - 2026)

TransMedics has reported Receivables for 9 years, with the latest figure at $104.1 million in Q2 2026.

• On a quarterly basis, Receivables fell 3.08% year-over-year to $104.1 million in Q2 2026; TTM through Jun 2026 was $104.1 million, a 3.08% decrease from a year earlier, with the FY2025 full-year figure at $84.3 million, down 13.75% from the prior year.
• Receivables was $104.1 million for Q2 2026 at TransMedics, up from $90.7 million in the prior quarter.
• The five-year high for Receivables was $142.0 million in Q1 2025, with the low at $11.7 million in Q1 2022.
• Average Receivables over 5 years is $69.2 million, with a median of $80.9 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Receivables jumped 430.96% in 2022, then sank 36.12% in 2026.
• Over 5 years, Receivables stood at $27.6 million in 2022, then surged by 130.26% to $63.6 million in 2023, then jumped by 53.71% to $97.7 million in 2024, then declined by 13.75% to $84.3 million in 2025, then rose by 23.56% to $104.1 million in 2026.
• The last three Receivables figures came in at $104.1 million (Q2 2026), $90.7 million (Q1 2026), and $84.3 million (Q4 2025), per Business Quant data.